Drugs Information: Sacituzumab govitecan
Basic Information
|
||
| ID | DDInter1629 | |
| Drug Type | biotech | |
| Molecular Formula | None | |
| Molecular Weight | - | |
| Description | Sacituzumab govitecan is sacituzumab govitecan targets TROP-2-expressing cancer cells through a humanized antibody (RS7) before subsequently becoming internalized and releasing the topoisomerase I inhibitor SN-38 to induce DNA damage-mediated apoptosis.[L13002] | |
| ATC Classification | - | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Sacituzumab govitecan
| Severity level | ID | Name | Mechanism | Detail |
|---|